Recruiting seniors into drug trials may help close evidence gap

Share this article:
A growing number of scientists are considering a new approach to drug trials. It includes "real world" testing on more elderly patients with multiple chronic conditions.

Most drug trials have relatively limited goals, and do not consider long-term effects and possible interactions with other diseases or other medications, according to The New York Times. This leaves what many scientists and doctors call an evidence gap, meaning that, while there is a lot of information on how a drug will react when a person is young and healthy there is almost no information on how these drugs will affect seniors with multiple conditions and prescriptions.

To correct this information imbalance, researchers are recruiting more seniors into clinical trials to get a better sense of how the drugs react and interact in a "real world" setting. To that end, many medical researchers, societies and insurers are asking Congress to establish an Institute for Comparative Effectiveness Research to identify and assess research gaps, according to the Times.
Share this article:

More in News

Nursing home administrators do not believe that pay-for-performance improves care quality or facility profitability, survey shows

Nursing home administrators do not believe that pay-for-performance ...

Most nursing home administrators do not believe that pay-for-performance initiatives lead to improved resident care or stronger bottom lines, according to findings recently published in the Journal of Aging and ...

Former CNA gets 16-year prison sentence for stealing nursing home residents' identities

Three former nursing home aides are facing prison time for stealing residents' identities and conning the government, state and federal authorities announced Thursday.

Aggression strongly signals pain only when dementia reaches advanced stages, researchers find

For a person with dementia, the link between aggressive behavior and physical pain is strong only in the condition's advanced stages, University of Florida researchers have found.